Share on LinkedInShare on LinkedIn

ARTICLE · 10 JANUARY 2018

Federal Court Declines To Assess Litigation Funding Arrangement

Seedling Life Science Ventures ("Seedlings") is the plaintiff in a patent infringement action against Pfizer relating to Patent No. 2,486,935 and auto injectors.

CanadaIntellectual Property

Seedling Life Science Ventures ("Seedlings") is the plaintiff in a patent infringement action against Pfizer relating to Patent No. 2,486,935 and auto injectors. Seedlings brought a motion seeking approval of a litigation funding agreement (LFA) with a third party (Bentham IMF Capital Limited, the Canadian subsidiary of IMF Bentham Ltd, a professional litigation funding enterprise from Australia), as required by the terms of the agreement: Seedling Life Science Ventures LLC v Pfizer Canada Inc, 2017 FC 826.

The LFA, to which Seedlings' counsel are also parties, provides that Bentham will fund Seedlings' legal fees and disbursements, and that each of Seedlings, Bentham and counsel for Seedlings will be entitled to financial returns from a successful outcome. Seedlings remains in control of the litigation but Bentham has the right to be consulted on settlement. Bentham will have access to all documents in the litigation, but will be subject to the same confidentiality

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from